Catheter Precision Inc (VTAK)
0.5771
+0.02
(+3.79%)
USD |
NYAM |
May 08, 16:00
0.5771
0.00 (0.00%)
After-Hours: 20:00
Catheter Precision Cash from Financing (Quarterly): -0.107M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.107M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.059M |
| March 31, 2023 | 8.434M |
| December 31, 2022 | 5.206M |
| September 30, 2022 | 7.495M |
| June 30, 2022 | -0.516M |
| March 31, 2022 | 11.18M |
| December 31, 2021 | 0.141M |
| September 30, 2021 | 4.266M |
| June 30, 2021 | 10.72M |
| March 31, 2021 | -0.163M |
| December 31, 2020 | -0.331M |
| September 30, 2020 | 10.34M |
| Date | Value |
|---|---|
| June 30, 2020 | 11.76M |
| March 31, 2020 | -0.076M |
| December 31, 2019 | -0.308M |
| September 30, 2019 | -0.094M |
| June 30, 2019 | -0.047M |
| March 31, 2019 | -0.077M |
| December 31, 2018 | 67.96M |
| September 30, 2018 | -0.538M |
| June 30, 2018 | 6.358M |
| March 31, 2018 | 1.391M |
| December 31, 2017 | 9.042M |
| September 30, 2017 | 1.316M |
| June 30, 2017 | 0.039M |
| March 31, 2017 | -0.011M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.516M
Minimum
Jun 2022
11.76M
Maximum
Jun 2020
3.576M
Average
0.059M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 0.352M |
| Retractable Technologies Inc | -0.1364M |
| InfuSystems Holdings Inc | -3.544M |
| Xtant Medical Holdings Inc | 0.325M |
| Asensus Surgical Inc | 0.172M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.889M |
| Cash from Investing (Quarterly) | -0.018M |
| Free Cash Flow | -20.70M |
| Free Cash Flow Per Share (Quarterly) | -0.2709 |
| Free Cash Flow to Equity (Quarterly) | -2.091M |
| Free Cash Flow to Firm (Quarterly) | -1.907M |
| Free Cash Flow Yield | -653.9% |